Pro members get same-minute coverage on the stocks they track. Free plans update twice a day.
Get ProCounts of positive, neutral, and negative news items. Not a price chart.
Informational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Showing 5 stories from 10 Jul 2026
Show allThe items moving the net sentiment the most, by direction and influence.
Dr Reddy's Semaglutide Supply Disruption Raises Growth Concerns
Direct news · Medium influence · Short term
Dr Reddy's Stock in Focus as Semaglutide Sales Halted and FY27 Target Cut
Direct news · Medium influence · Short term
Dr Reddy's Pauses Semaglutide Supply Over Impurity Concerns
Direct news · Medium influence · Short term
RBI Spends Record Reserves Defending Rupee, Faces $100 Billion Test
Indian rupee / INR-USD · Low influence · Short term
Macro, commodity, FX and regulatory forces that moved DRREDDY in this range, with the stories behind each.
Also monitored for DRREDDY (no news in this range): US FDA / USFDA.
Sign up free to track DRREDDY, unlock full history and the complete driver breakdown, and get alerts when sentiment shifts.
Track DRREDDY for freeInformational only, not investment advice. Sentiment reflects news exposure, not a buy/sell recommendation or price forecast. Do your own research and consult a licensed professional.
Axis Bank, Dr Reddy's, Hindalco and Nestle India Among Stocks With Dividend, Bonus or Split Actions on July 10
How news sentiment on Dr. Reddy's Laboratories Ltd. (DRREDDY) has built up over time. Each bar sums the direction of every story TradeTidings published in the period, weighted by how influential we rated it, not just a plain count, so a single high-influence negative story can outweigh several small positive ones. Hover a bar for its exact figures, or click one to filter the stories below to that period. Our own original analysis, not a copied index or a price chart, and not a prediction.
